Here are relevant reports on : diy-home-improvement-market
-
Wound Care Market by Product (Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers), Wounds (Chronic, Acute)), End User (Hospitals, Clinics, Home Care), and Region - Global Forecast to 2030
The global wound care market, valued at USD 20.97 billion in 2024, stood at USD 22.22 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of USD 30.48 billion by the end of the period. The wound care market is primarily driven by the increasing cases of traumatic and burn injuries, growing prevalence of chronic diseases, and rising geriatric population. These factors have contributed to the higher demand for effective wound management solutions.
- Published: July 2025
- Price: $ 8150
- TOC Available:
-
Surfactants Market by Type (Anionic, Non-ionic, Cationic and Amphoteric), Application (Home Care, Personal Care, I&I Cleaners, Food & Beverage, Oilfield Chemicals, Agrochemicals, Textiles, Elastomers & Plastics), and Region - Global Forecast to 2031
The surfactants market size was USD 52.25 billion in 2026 and is projected to reach USD 66.95 billion by 2031, at a CAGR of 5.08% between 2026 and 2031. The key players include BASF SE (Germany), Stepan Company (US), Dow Inc. (US), Evonik Industries AG (Germany), Nouryon (Netherlands), Solvay S.A. (Belgium), Clariant AG (Switzerland), Indorama Ventures Public Company Limited (Thailand), Ashland Inc. (US), Kao Corporation (Japan), and Croda International Plc (UK).
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017
The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE).
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
North American Home Healthcare Market By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation Therapy] & Telehealth - Forecasts To 2017
The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) - Global Forecast to 2020
The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020. Continuous technological advancements in automation solutions, increasing government financial support for medical automation, rising labour costs, and growing need for reproducibility and accuracy are key factors fuelling the growth of the medical automation market. Increasing demand for automation in laboratories and pharmacies and high potential for early detection and treatment of diseases due to automation are some other prime factors offering growth opportunities for players in the medical automation market. However, high cost of automation is one of the key restraints for this market.
- Published: February 2016
- Price: $ 4950
- TOC Available:
-
Biocides Market by Type (Non-oxidizing Biocides, Oxidizing Biocides), Application (Water Treatment, Industrial & Institutional Cleaning and Home Care, Paints & Coatings, Wood Preservatives), and Region - Global Forecast to 2029
The biocides market is expected to grow from USD 9.72 billion in 2024 to USD 12.34 billion by 2029, at a CAGR of 4.9% during the forecast period. The key market players identified in the report are LANXESS AG (Germany), Veolia Group (France), Arxada AG (Switzerland), Ecolab Inc. (US), Nouryon (Netherlands), General Electric Company (US), Evonik Industries AG (Germany), Solvay SA (Belgium), and Clariant AG (Switzerland).
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Electronic Sensors Market For Consumer Industry by Type (Image, Motion, Pressure, Temperature, Fingerprint, Proximity, & Others), Application (Communication & IT, Entertainment, Home Appliances, & Wearable Devices), and Geography - Global Forecast to 2022
The electronic sensors market for consumer industry is expected to reach USD 26.76 Billion by 2022, at a CAGR of 12.26% between 2016 and 2022. Market players involved in the manufacturing of electronic sensors include Sony Corporation (Japan), Samsung Electronics Co., Ltd.(South Korea), STMicroelectronics N.V.(Switzerland), NXP Semiconductors N.V.,(acquired by Qualcomm), TE Connectivity Ltd. (Switzerland), Murata Manufacturing Co., Ltd.(Japan), Robert Bosch GmbH (Germany), Infineon Technologies AG (Germany), Synaptics Incorporated (US) Cypress Semiconductor Corporation (US) and Omron Corporation (Japan) are focusing on product launches, research and development, acquisitions, and collaborations to enhance their product offerings and business expansion.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
Fog Computing Market by Offering (Hardware, Software), Application (Building & Home Automation, Smart Energy, Smart Manufacturing, Transportation & Logistics, Connected Health, Security & Emergencies), and Geography - Global Forecast to 2035
The global Fog Computing Market is entering a high-growth phase as enterprises increasingly shift from centralized cloud architectures toward distributed computing environments that process data closer to connected devices, machines, sensors, and users. The growth trajectory is being shaped by rapid Internet of Things (IoT) adoption, artificial intelligence (AI), industrial automation, 5G connectivity, smart-city development, connected healthcare, autonomous systems, and digital transformation.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Cardiac Rhythm Management Market by Product (Implantable, External Pacemakers, Defibrillators, Cardiac resynchronization therapy (CRT) devices), by End-Users (Hospitals, Home, Ambulatory) Forecasts To 2020
The incidence of cardiovascular diseases (CVD) is increasing with the aging population, changing lifestyle, and increasing stress. It is estimated that 17 million people die of CVD every year. Sudden cardiac arrest (SCA) is the leading cause of death among U.S. adults aged 40 years and above. According to Centre for Disease Control and Prevention (CDC), approximately 250,000 people die every year in the U.S. from SCA.
- Published: September 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
